Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Detailed price information for Palvella Therapeutics Inc (PVLA-Q) from The Globe and Mail including charting and trades.

A new report published in Brain Medicine reveals that a single dose of the drug Osanetant, administered shortly after a ...

Blagosklonny goes on to write that even though rapamycin may reverse some manifestations of aging, it is more effective at ...

Can the key to a longer, healthier life be found in your kitchen? As the global population ages, scientists have uncovered ...

A new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...

Microcystic LMs are a rare, chronically debilitating genetic disease caused by dysregulation of the phosphatidylinositol ...

A team led by Prof. Wuran Wei from West China Hospital of Sichuan University and Dr. Dechao Feng from the Division of Surgery ...

Innovations in therapeutic strategies, coupled with a deeper understanding of breast cancer biology, will be essential for advancing personalized ...

One of these, a pathway called mTOR that's involved in cell growth and metabolism, was overactive in axonal spheroids. So, the team conducted an additional experiment in which they applied amyloid ...